Incidence of cardiometabolic and pulmonary events in UK has lowered due to COVID-19


Caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, coronavirus disease 2019 (COVID-19) is speculated to be involved in various pulmonary and cardiometabolic conditions. A team of researchers from the University of Oxford, the London School of Hygiene and Tropical Medicine and other institutions recently analyzed extensive data collected by NHS England to reveal any association between SARS-CoV-2 infection and cardiometabolic or respiratory events.

Interestingly, the group noted a drop in the incidence of such events in the non-COVID-19 population, but a high incidence of COVID-19 among patients with events. The team has recently released their findings on the medRxiv* preprint server.

How was the analysis performed?

NHS England has elected to publish extensive patient records for research and analysis in light of the pandemic on the OpenSAFELY server, which now contains records for over seventeen million adult patients. The group utilized this entire dataset and took into account information regarding death, the development of deep vein thrombosis, ischaemic stroke, pulmonary embolism, heart failure, myocardial infarction, diabetic ketoacidosis, or acute kidney injury for each month. The dataset was split into three categories: community patients with COVID-19, hospitalized patients with COVID-19, and those without COVID-19…

Want to know more click here go to source.

From -
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.